Angiodynamics (ANGO) Non-Current Assets (2011 - 2026)
Angiodynamics' (ANGO) quarterly Non-Current Assets came in at $103.8 million in Q2 2026, down 7.2% YoY from $111.8 million in Q2 2025, and down 1.29% on a QoQ basis from $105.1 million in Q1 2026.
Angiodynamics (ANGO) Non-Current Assets (2011 - 2026) Analysis & Trends
Angiodynamics (ANGO) has 16 years of Non-Current Assets data on file, last reported at $103.8 million in Q2 2026.
- Quarterly Non-Current Assets fell 7.2% year-over-year to $103.8 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $426.2 million (down 7.77% YoY) and the FY2026 annual result came in at $103.8 million, down 7.2% from the prior year.
- Non-Current Assets fell to $103.8 million in Q2 2026, from $105.1 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $415.5 million in Q1 2022 to a low of $103.8 million in Q2 2026.
- A 5-year average of $231.3 million and a median of $126.2 million in 2024 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets decreased 2.65% — and 2024, when it plunged 67.22%.
- Tracing ANGO's Non-Current Assets over 5 years: stood at $399.4 million in 2022, then slipped by 21.34% to $314.1 million in 2023, then plunged by 63.01% to $116.2 million in 2024, then slipped by 6.76% to $108.3 million in 2025, then fell by 4.21% to $103.8 million in 2026.
- The last three Non-Current Assets figures came in at $103.8 million (Q2 2026), $105.1 million (Q1 2026), and $108.3 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 11.33 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 42.59 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 24.47 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 4.64 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 27.61 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 2.27 Bn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 10.50 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 10.18 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 12.80 Bn |
| 10 | Angiodynamics | 658.19 Mn | 604.32 Mn | 46.77 Mn | 103.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 103.77 Mn |
| Feb 28, 2026 | 105.13 Mn |
| Nov 30, 2025 | 108.33 Mn |
| Aug 31, 2025 | 108.99 Mn |
| May 31, 2025 | 111.82 Mn |
| Feb 28, 2025 | 113.13 Mn |
| Nov 30, 2024 | 116.19 Mn |
| Aug 31, 2024 | 121.01 Mn |
| May 31, 2024 | 124.42 Mn |
| Feb 29, 2024 | 127.94 Mn |
| Nov 30, 2023 | 314.13 Mn |
| Aug 31, 2023 | 318.47 Mn |
| May 31, 2023 | 369.10 Mn |
| Feb 28, 2023 | 390.23 Mn |
| Nov 30, 2022 | 399.38 Mn |
| Aug 31, 2022 | 406.28 Mn |
| May 31, 2022 | 409.41 Mn |
| Feb 28, 2022 | 415.49 Mn |
| Nov 30, 2021 | 421.92 Mn |
| Aug 31, 2021 | 424.44 Mn |